INSEEGO CORP
For the period ended Mar 31, 2025. Filed May 9, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 9, 2025
INSG$4.22+8.9%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 1. Financial Statements
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except par value, share and per share data)
| March 31,2025 | December 31,2024 | |
|---|---|---|
| (Unaudited) | ||
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $35,149 | $39,596 |
| Accounts receivable, net of allowance for expected credit losses of $144 and $123, respectively | 12,091 | 13,803 |
| Inventories | 15,113 | 13,575 |
| Prepaid expenses and other | 3,808 | 5,926 |
| Total current assets | 66,161 | 72,900 |
| Property, plant and equipment, net of accumulated depreciation of $29,119 and $28,897, respectively | 922 | 1,102 |
| Intangible assets, net of accumulated amortization of $35,180 and $33,558, respectively | 18,864 | 18,747 |
| Goodwill | 3,949 | 3,949 |
| Operating lease right-of-use assets | 2,592 | 2,855 |
| Other assets | 508 | 446 |
| Total assets | $92,996 | $99,999 |
| LIABILITIES AND STOCKHOLDERS’ DEFICIT | ||
| Current liabilities: | ||
| Accounts payable | $18,059 | $18,433 |
| Accrued expenses and other current liabilities | 26,066 | 30,133 |
| 2025 Convertible Notes, net | 14,938 | 14,905 |
| Total current liabilities | 59,063 | 63,471 |
| Long-term liabilities: | ||
| Operating lease liabilities | 2,262 | 2,627 |
| Deferred tax liabilities, net | 177 | 174 |
| 2029 Senior Secured Notes, net | 41,775 | 41,830 |
| Other long-term liabilities | 2,714 | 4,755 |
| Total liabilities | 105,991 | 112,857 |
| Commitments and contingencies (Note 10.) | ||
| Stockholders’ deficit: | ||
| Preferred stock, par value $0.001; 2,000,000 shares authorized: | ||
| Preferred stock, par value $0.001; 39,500 shares designated, 25,000 shares issued and outstanding as of both March 31, 2025 and December 31, 2024 (aggregate liquidation preference of $39,256 as of March 31, 2025) | — | — |
| Common stock, par value $0.001; 150,000,000 shares authorized, 15,007,437 and 14,990,712 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively | 15 | 15 |
| Additional paid-in capital | 894,825 | 892,534 |
| Accumulated other comprehensive loss | 224 | 218 |
| Accumulated deficit | (908,059) | (905,625) |
| Total stockholders’ deficit | (12,995) | (12,858) |
| Total liabilities and stockholders’ deficit | $92,996 | $99,999 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.